Investors / Japan / Kobe University Capital
Kobe University Capital
Venture capital · Kobe, Japan · Asia Pacific
Kobe University Capital is a venture capital firm that operates venture capital funds, including the Kobe University Fund. It works with Kobe University and Kobe University Innovation to invest in and support startups that commercialize academic and research results from the university and the region.
Invests inHealthcare & Biotech
In its own wordsdeep techuniversity spinoutsacademiaregional developmentkansaijapan
Your fit with Kobe University Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsKobe University Capital lists 14 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (59%), Cybersecurity (14%) and Space & Defense (5%). 100% of its companies are based in Japan. It invests most often alongside OSAKA University Venture Capital, DBJ Capital and Global Brain.
Counts come from funding rounds that name Kobe University Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Kobe University Capital's whole history. Rounds on record name 1 company; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundKobe University Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 46th | 18 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 88th | 59% in its largest sector |
| Reach | 19th | 1 country |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 59% | 15% |
| Cybersecurity | 14% | 4% |
| Space & Defense | 5% | 3% |
| Consumer | 5% | 3% |
| Education | 5% | 7% |
| Human Resources | 5% | 1% |
| AI & Machine Learning | 5% | 18% |
| Industrial & Manufacturing | 5% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| OSAKA University Venture Capital | 4 |
| DBJ Capital | 2 |
| Global Brain | 2 |
| Nippon Venture Capital | 2 |
| Asahi Kasei Ventures | 1 |
| Axil Capital | 1 |
| D4V | 1 |
| GLIN Impact Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers14100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with OSAKA University Venture Capital
Compare Kobe University Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Kobe University Capital| Date | Company | Stage |
|---|---|---|
| 24 Sept 2026 | Series A |
Round details for Kobe University Capital
Amounts, full round histories and every co-investor in Kobe University Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alpha Fusion develops targeted alpha therapy for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| The company provides contract manufacturing and quality control testing for gene and cell therapies | Healthcare & Biotech | Portfolio page | ||
| The company develops and provides technology, including membrane technology, and conducts research and development | Industrial & Manufacturing | Portfolio page | ||
| Hedgehog Medtech develops and manufactures medical technology products, including an AI-powered headache diagnosis program. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company develops nucleic acid pharmaceuticals. | Healthcare & Biotech | Portfolio page | ||
| PITTAN develops a sweat analysis kit to optimize nutritional balance | Healthcare & Biotech | Portfolio page | ||
| SecureNavi provides a cloud service for managing ISMS certification and P-Mark operation | CybersecuritySpace & Defense | Portfolio page | ||
| Sinumy develops Bluetooth-based hands-free authentication technology that identifies a person's smartphone position to within a few centimeters for use in transit gates, payments, and smart locks. | CybersecurityConsumer | Portfolio page | ||
| TCN Prime develops and sells medical devices, including catheters and other equipment for cardiovascular treatment. | Healthcare & Biotech | Portfolio page | ||
| TearExo provides tear fluid inspection services for breast cancer risk monitoring | Healthcare & Biotech | Portfolio page | ||
| The company provides various services, including a family app, photography and video services, career schools, and recruitment services, to support families and working mothers. | EducationHuman Resources | Portfolio page | ||
| United Immunity develops next-generation in vivo cell therapies using its Myeloid Targeting Platform technology to selectively target and program immune cells in the body for the treatment of various diseases. | Healthcare & Biotech | Sept 2026Series A | Funding round | |
| The company develops gene therapy for inherited retinal diseases | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- kuc.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 24 Sept 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Kobe University Capital's profile as data
Pull Kobe University Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/kuc.vc
# also
GET /v1/firms/kuc.vc/portfolio
GET /v1/firms/kuc.vc/coinvestors
GET /v1/firms/kuc.vc/news